Clinical trial
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting…
NCT00301522 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00301522 |
|---|---|
| Title | Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions |
| Official title | TAXUS V: De Novo Lesion: A Randomized, Double-blind Trial to Assess TAXUS Paclitaxel-Eluting Coronary Stents, SR Formulation, in the Treatment of De Novo Coronary Lesions |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Stenosis |
| Intervention type | Device |
| Interventions | TAXUS Paclitaxel-Eluting Coronary Stent, Slow-Formulation, Express2 |
| Enrollment | 1,108 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Apr 1, 2009 |
| First posted | Mar 13, 2006 |
| Last update posted | Aug 6, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: